Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects.

Colleoni, M; Orlando, L; Sanna, G; Rocca, A; Maisonneuve, P; Peruzzotti, G; Ghisini, R; Sandri, M T; Zorzino, L; Nolè, F; Viale, G; Goldhirsch, A

Colleoni, M; Orlando, L; Sanna, G; Rocca, A; Maisonneuve, P; Peruzzotti, G; Ghisini, R; Sandri, M T; Zorzino, L; Nolè, F; Viale, G; Goldhirsch, A.

Affiliation

Colleoni M; Division of Medical Oncology, University of Milan School of Medicine, European Institute of Oncology, Milan, Italy. marco.colleoni@ieo.it

Ann Oncol ; 17(2): 232-8, 2006 Feb.

Article in En | MEDLINE | ID: mdl-16322118

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/drug therapy; Administration, Oral; Adult; Aged; Angiogenesis Inhibitors/administration & dosage; Antimetabolites, Antineoplastic/administration & dosage; Antineoplastic Agents, Alkylating/administration & dosage; Breast Neoplasms/blood; Breast Neoplasms/pathology; Cyclophosphamide/administration & dosage; Female; Humans; Methotrexate/administration & dosage; Middle Aged; Neoplasm Metastasis; Thalidomide/administration & dosage; Treatment Outcome; Vascular Endothelial Growth Factor A/blood

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2006 Document type: Article Affiliation country: Italy Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links